Insights

Here’s what happened to the CSL share price in June

CSL shares were relatively positive performers in June…
The post Here’s what happened to the CSL share price in June appeared first on The Motley Fool Australia. –

The CSL Limited (ASX: CSL) share price had an eventful month in June.

Although the biotherapeutics giant’s shares ended the period largely flat, this was actually a very good outcome for investors.

That’s because the CSL share price was down by 6% in the middle of the month but rebounded strongly.

Furthermore, it was significantly better than the performance of the ASX 200 index, which lost approximately 9% of its value during the period.

Why did the CSL share price outperform?

The outperformance of the CSL share price appears to have been driven by the release of some bullish broker notes.

One of those came from the team at Citi, which retained its buy rating with a slightly trimmed price target of $330.00. This price target implies potential upside of almost 20% for investors over the next 12 months.

Citi highlighted that plasma collection levels have now returned to pre-COVID levels and immunoglobulins pricing is increasing. And with demand remaining strong for plasma products, the broker appears to believe the tide is now turning for CSL.

In light of this, the broker suspects that the market will start to focus on demand rather than supply. And given that demand is strong, it feels that this should bode well for the CSL share price performance in the coming months.

Citi explained:

Recently, there have been several data points influencing our view on the plasma sector. In this report, we review them and the implications for the sector as a whole. US CMS data indicates continued price increases in immunoglobulin products. This is consistent with our expectation, as donor fees continue to remain elevated.

Underlying demand for plasma products remains strong but supply is constrained due to low plasma collection volume. With plasma collections now back to pre-pandemic levels, we expect the market to shift its focus to the strong underlying plasma product demand. This should lead to strength in the CSL share price. Maintain Buy, A$330 TP.

The post Here’s what happened to the CSL share price in June appeared first on The Motley Fool Australia.

Should you invest $1,000 in Csl Limited right now?

Before you consider Csl Limited, you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Csl Limited wasn’t one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

See The 5 Stocks
*Returns as of June 1 2022

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

How did the Vanguard Australian Shares Index ETF perform in June?
Leading brokers name 3 ASX shares to buy today
Here’s how ASX 200 healthcare shares performed in June
Why a CSL share price above $300 is on the cards: expert
ASX 200 healthcare shares provided some pain relief today. Here’s why

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

  • This field is for validation purposes and should be left unchanged.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Rebate Rewards

Level 2 Rebate

Deposit $2,000 and get $200 Rebate
$ 200 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $2,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $200 Rebate
Popular

Level 1 Rebate

Deposit $1,000 and get $100 Rebate
$ 100 Rebate
  • 3 Simple Steps
  • 1. Register Using The Link Below (Promo-Code: WEBREBATE)
  • 2. Deposit $1,000 and place one trade at any non-Austalian market within 30 calendar days
  • 3. Receive Your $100 Rebate

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex Securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

EASY QUALIFICATION & LOW ENTRY
NEW CLIENT REBATE OFFER
EARN UP TO $200 CASH REBATE
Act Fast - Promotion Ends In
Click Here To Get Started
EASY QUALIFICATION & LOW ENTRY
NEW CLIENT REBATE OFFER
EARN UP TO $200 CASH REBATE
Act Fast - Promotion Ends In
Click Here For More Info